Abstract
The frequency of HLA-DQ antigens in AIDS patients with toxoplasmic encephalitis (TE) were examined. HLA-DQ3 was significantly more frequent in white North American AIDS patients with TE (85.0%) than in the general white population (51.8%; P = .007, corrected P = .028) or randomly selected control AIDS patients who had not developed TE (40.0%; P = .016). In contrast, the frequency of HLA-DQ1 was lower in TE patients than in healthy controls (40.0% vs. 66.5%, P = .027), but this difference did not reach statistical significance when corrected for the number of variables tested (corrected P = .108 for the general white population). HLA-DQ3 thus appears to be a genetic marker of susceptibility to development of TE in AIDS patients, and DQ1 may be a resistance marker. These HLA associations with disease indicate that development of TE in AIDS patients is affected by a gene or genes in the HLA complex and that HLA-DQ typing may help in decisions regarding TE prophylaxis.
Original language | English |
---|---|
Pages (from-to) | 265-268 |
Number of pages | 4 |
Journal | Journal of Infectious Diseases |
Volume | 173 |
Issue number | 1 |
DOIs | |
State | Published - 1996 |
Bibliographical note
Funding Information:Received 17 January 1995; revised 17 July 1995. Financial support: Japan Immunoresearch Company; National Institutes of Health (AI-04717 and HL-33811); and Health Manpower Development Plan scholarship, Ministry of Health, Singapore (to S.-Y.W.). Reprints or correspondence: Dr. Jack S. Remington, Dept. of Immunology and Infectious Diseases, Research Institute, Palo Alto Medical Foundation, Palo Alto, CA 94301. • Current affiliation: Department ofInfectious Diseases, Communicable Disease Center, Tan Tock Seng Hospital, Singapore (S.-Y.W.); Staedtisches Krankenhaus Hildesheim 31134, Hildesheim, Germany (S.K.).
Funding
Received 17 January 1995; revised 17 July 1995. Financial support: Japan Immunoresearch Company; National Institutes of Health (AI-04717 and HL-33811); and Health Manpower Development Plan scholarship, Ministry of Health, Singapore (to S.-Y.W.). Reprints or correspondence: Dr. Jack S. Remington, Dept. of Immunology and Infectious Diseases, Research Institute, Palo Alto Medical Foundation, Palo Alto, CA 94301. • Current affiliation: Department ofInfectious Diseases, Communicable Disease Center, Tan Tock Seng Hospital, Singapore (S.-Y.W.); Staedtisches Krankenhaus Hildesheim 31134, Hildesheim, Germany (S.K.).
Funders | Funder number |
---|---|
Japan Immunoresearch Company | |
Ministry of Health, Government of Singapore | |
National Institutes of Health (NIH) | HL-33811 |
National Institute of Allergy and Infectious Diseases | R37AI004717 |
ASJC Scopus subject areas
- Immunology and Allergy
- Infectious Diseases